Investigational Site Number :3760003

Tel Aviv 6423906

0 studies enrolling now · 5 studies all time

What they study most

Breast Cancer Metastatic, Chronic Kidney Diseases, Eosinophilic Oesophagitis, Glycogen Storage Disease Type II, Heart Failure, Plasma Cell Myeloma, Pompe Disease, Type 2 Diabetes Mellitus

Studies at this site

• Pompe Disease Registry Protocol — Recruiting now
• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early
• A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial) — Running, not enrolling
• Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma — Running, not enrolling
• Effect of Sotagliflozin on Cardiovascular and Renal Events in Participants With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk — Stopped early